Stockholder's Equity - Schedule of Stock Option Activity (Details) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
Dec. 31, 2025 |
Sep. 30, 2025 |
|
| Schedule of Stock Option Activity [Abstract] | ||||
| Shares, Outstanding Balance | 18,100,000 | 12,750,000 | 18,100,000 | 18,100,000 |
| Weighted-Average Exercise Price, Outstanding Balance | $ 1.83 | $ 2.15 | $ 1.83 | $ 1.83 |
| Weighted-Average Remaining Contractual Term, Outstanding Balance | 8 years 2 months 15 days | 7 years 9 months 3 days | 7 years 11 months 8 days | |
| Aggregate Intrinsic Value, Outstanding Balance | $ 5,386,000 | $ 5,386,000 | ||
| Shares, Exercisable | 9,781,250 | 11,316,667 | 9,781,250 | |
| Weighted-Average Exercise Price, Exercisable | $ 1.9 | |||
| Weighted-Average Remaining Contractual Term, Exercisable | 8 years 9 months 10 days | 7 years 6 months 10 days | 8 years 2 months 15 days | |
| Aggregate Intrinsic Value, Exercisable | ||||
| Shares, Granted | 5,750,000 | |||
| Weighted-Average Exercise Price, Granted | $ 1.07 | |||
| Shares, Forfeited | ||||
| Weighted-Average Exercise Price, Forfeited | $ 1.75 |
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|